APOTHEEK KROONPLEIN
ActiveSummary
APOTHEEK KROONPLEIN has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €146,558 and a net result of €66,435. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 57% of 9,537 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 1.2% (low).
Overview
Official details
Source: KBO- Status
- Active since 16-11-1989 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730and 1 other
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2021
- Establishment unit
- 2.047.943.677 2170 Antwerpen, since 19-04-1990
- Financial year end
- 31 December
- Peppol
- Reachable
Board and ownership
- GOVEMEDDirector · permanent representative Victor Görtz
- GOVEMED100%· score 6531-03-2025 annual accounts of GOVEMED
- APOTHEEK GORTZ0.2%· score 562024 annual accounts of APOTHEEK GORTZ
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.2%
- Gross margin
- €172,586
- ▲ 40.0%
- Turnover
- ≈ €810,000
- estimated
- Profit
- €66,435
- ▲ 409%
- Equity
- €146,558
- ▲ 22.0%
- Total assets
- €332,428
- ▲ 19.6%
- Employees on 31-12-2024
- 2
- =
- 2025 accounts not filed, 95 days past the deadline
Score breakdownraises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed on 29-08-2025)Sector: Retail trade (NACE 47)lowers riskFounded in 1989Equity €146,558 (44.1% of total assets)Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 59% of them on solvency, 31% on liquidity, 88% on profitability and 74% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 6 accounts on average 8 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
Key points
Recent changes
- · Gazette deed 2 directors resigning, 2 reappointedResignations: GOVEMED (manager) and Victor Görtz (manager) · Reappointments: GOVEMED (director) and Victor Görtz (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTHEEK KROONPLEIN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €228,000 and €415,000, founded between 1974 and 1996.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK KROONPLEIN Antwerpen | €332,428 | €172,586 |
| APOTHEEK BEERT - VERSWIJVEL Laakdal | €290,401 | €126,016 |
| APOTHEEK VAN DEN BOSCH Herentals | €399,030 | €176,637 |
| APOTHEEK DE GAPER Mortsel | €228,107 | €157,365 |
| APOTHEEK LEURIDAN A. Antwerpen | €414,648 | €206,449 |
| Pharmacie de Fragnée Liège | €380,921 | €132,360 |
| STEVENS PHARMA Wezembeek-Oppem | €406,503 | €165,069 |
Key facts about APOTHEEK KROONPLEIN
- What is the company number of APOTHEEK KROONPLEIN?
- The company number of APOTHEEK KROONPLEIN is 0440.018.823. The VAT number is the same number with BE in front: BE 0440.018.823.
- Where is APOTHEEK KROONPLEIN based?
- The registered office is at Kroonplein 47, 2170 Antwerpen.Company details
- What does APOTHEEK KROONPLEIN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK KROONPLEIN?
- The legal form of APOTHEEK KROONPLEIN is Private limited company (BV).
- When was APOTHEEK KROONPLEIN founded?
- APOTHEEK KROONPLEIN was founded on 16-11-1989.
- Is APOTHEEK KROONPLEIN still active?
- Yes, APOTHEEK KROONPLEIN is an active enterprise in the KBO register.
- How many employees does APOTHEEK KROONPLEIN have?
- APOTHEEK KROONPLEIN had an average of 0.9 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK KROONPLEIN fall under?
- In its 2021 annual accounts, APOTHEEK KROONPLEIN states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK KROONPLEIN?
- The turnover in financial year 2024 is ≈ €810,000. This figure is estimated from the gross margin of €172,586 and 51 comparable companies (NACE 477). It probably lies between €550,000 and €1.6m.
- Is APOTHEEK KROONPLEIN profitable?
- In financial year 2024, APOTHEEK KROONPLEIN made a profit of €66,435.
- Where can I find the annual accounts of APOTHEEK KROONPLEIN?
- APOTHEEK KROONPLEIN filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.